期刊文献+

辛伐他汀对缺氧/复氧诱导的心肌细胞凋亡的拮抗作用及其作用机制 被引量:2

Protective effects and mechanism of simvastatin on hypoxia/reoxygenation-induced apoptosis in rat cardiomyocyte
下载PDF
导出
摘要 目的:探讨辛伐他汀对缺氧/复氧诱导的心肌细胞损伤的拮抗作用及潜在机制。方法:分离培养Sprague-Dawley(SD)大鼠(乳鼠)心肌细胞,随机分为对照组、缺氧2 h/复氧4 h(H/R4h)组、不同浓度(0.1、1.0及10μmol/L)的辛伐他汀干预组及Toll样受体4(TLR4)中和性抗体MTS510组(浓度为10μg/L)。H/R4h组给予缺氧2 h后,随即复氧4 h。细胞处理后,进行PI-AnnexinV染色用流式细胞仪检测心肌细胞的凋亡率,用ELISA法检测心肌乳酸脱氢酶(LDH)的活性;用免疫印迹法测TLR4蛋白的含量。结果:与H/R4h组相比,辛伐他汀干预组可显著降低心肌细胞的凋亡率(16.0%vs.28.6%,P<0.01)及LDH的活性(P<0.01),并呈剂量依赖性。中浓度的辛伐他汀组开始出现拮抗作用,峰值出现在高浓度辛伐他汀组,加入MTS510阻断剂可降低心肌细胞的凋亡率及LDH的活性(P<0.01)。结论:辛伐他汀对H/R造成的心肌细胞损伤具有拮抗作用,并呈剂量依赖性,其作用机制可能与TLR4信号通路有关。 AIM: To explore the protective effects and mechanism of simvastatin on hypoxia/reoxygenation-induced cardiac injury.METHODS: Cultured cardiomyocytes from neonatal rats subjected to hypoxia for 2 h and reoxygenation for 4 h were divided randomly into four groups: control group,hypoxia 2h/reoxygenation 4 h group(H/R 4 h),simvastatin(SIM) pretreated group(concentration: 0.1 μmol/L,1 μmol/L,10 μmol/L),and neutralizing antibody group of TLR4: MTS510(10 μg/L).Cardiomyocyte apoptosis was detected by flow cytometry,concentration of LDH was measured by ELISA and expression of TLR4 protein was measured by Western blot.RESULTS: Compared with that in control and H/R 4 h groups,H/R-induced apoptosis was markedly attenuated in SIM group in a dose-dependent manner.Protective effects of simvastatin began at 0.1 μmol/L and the maximal effects reached at 10 μmol/L.After the addition of neutralizing antibody of TLR4,cardiocyte apoptosis and activities of LDH decreased.CONCLUSION: Simvastatin protects hypoxia/reoxygenation-induced cardiac injury in a dose-dependent manner,and the protective effects are in association with TLR4 signalling pathway.
出处 《心脏杂志》 CAS 2011年第2期189-192,213,共5页 Chinese Heart Journal
关键词 辛伐他汀 缺氧/复氧 凋亡 TLR4 心肌细胞 simvastatin hypoxia/reoxygenation apoptosis TLR4 cardiac myocytes
  • 相关文献

参考文献32

  • 1Schulze CJ, Wang W, Suarez-Pinzon WL, et al. Imbalance between tissue inhibitor of metalloproteinase-~ and matrix metalloproteinases during acute myocardial [ correction of myoctardial] ischemia-reper- fusion injury[ J ]. Circulation, 2003, 107 (19) :2487 - 2492.
  • 2Scarabelli TM, Knight R, Stephanou A, et al. Clinical implications of apoptosis in ischemic myocardium [ J ]. Curr Probl Cardiol, 2006, 31(3) :181 -264.
  • 3Yang J, Yang J, Ding JW, et al. Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reper- fusion injury[J]. Inflammation, 2008, 31(5):304-312.
  • 4Effect of simvastatin on coronary atheroma: the Multicentre Anti- Atheroma Study (MAAS) [ J ]. Lancet, 1994, 344 ( 8923 ) : 633 - 638.
  • 5Szarszoi O, Maly J, Ostadal P, et al. Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in iso- lated rat heart[ J]. Physiol Res, 2008, 57 (5) :793 - 796.
  • 6Bergmann M W, Rechner C, Freund C, et al. Statins inhibit reoxy- genation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin [ J ]. J Mol Cell Cardiol, 2004, 37 (3) :681 - 690.
  • 7Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin ad- ministration : the role of toll-like receptor- 4 [ J ]. J Infect Dis, 2001, 183(11) :1617 -1624.
  • 8Takeda K, Akira S. Toll-like receptors[ J]. Curr Protoc Immunol, 2007, Chapter 14:Unit14.12.
  • 9Takeda K, Kaisho T, Akira S. Toll-like receptors [ J ]. Annu Rev Immunol, 2003, 21:335 - 376.
  • 10Verma S, Rao V, Weisel RD, et al. Novel cardioprotective effects of pravastatin in human ventrieular cardiomyocytes subjected to hy- poxia and reoxygenation : beneficial effects of statins independent of endothelial cells [ J ]. J Surg Res, 2004, 119 ( 1 ) :66 - 71.

二级参考文献21

  • 1孙涛,苏全生.自由基与心肌缺血/再灌注损伤[J].实用医院临床杂志,2006,3(4):94-96. 被引量:21
  • 2Schulze CJ,WangW, Kumari R, et al. Imbalance between tissue inhibitor of metallop reteinase - 4 and matrixmetallop reteinases during acute myocardial correction of myocardial ischemia - reperfusion injury. Circulation, 2003, 107 (19) : 2487 -2492
  • 3Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease : the Sandinavian Simvastatin Survival Study (4S). Lancet, 1994,344 : 1383 - 1389
  • 4Ambrosio G, Tritto I. Clinicalmanifestations ofmyocardial stunning. Coron Artery Dis, 2001, 12 (5) : 357 -361
  • 5Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation, 2001, 104 (24) : 2981 -2989
  • 6Cascio WE, Yang H, Johnson TA, et al. Electrical properties and conduction in repeffused papillary muscle. Circ Res, 2001, 89:807-814
  • 7Topoi EJ , Yadav JS. Recognition of the importance of embolization in atheroaclerotic vascular disease. Circulation, 2000, 101: 570 - 580
  • 8Scarabelli TM, Knight R, Stephanou A, et all Clinical implications of apoptosis in ischemic myoeardium . Curr Probl Cardiol, 2006, 31 ( 3 ) :181 -264
  • 9SdznerM, Rudiger HA, SdznerN1Transgenic mice overexp ressing human are resistant to hepatic ischemia and reperfusion. J Hepatol, 2002, 36(2) : 218-225
  • 10Melo LG,Agrawal R, Zhang L, et al. Gene therapy strategy for long term myocardial protection using adeno -associated virus - mediated delivery of heine oxygenase gene. Circulation, 2002,105 (5) : 602-607

共引文献2

同被引文献24

  • 1Ye Y,Martinez JD,Perez-Polo RJ,et al.The role of eNOS,iNOS, and NF-kappaB in upregulation and activation of cyclooxyge- nase-2 and infarct size reduction by atorvastatin[J]. Am J Physiol Heart Circ Physiol, 2008,295 ( 1 ) : 343-351.
  • 2Ishida K,Geshi T,Nakano A,et al.Beneficial effects of statin treat- ment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction [J].Int JCardio1,2012,155 (3) :442-447.
  • 3Fan Y, Yang S, Cao Y, et al. Effects of acute and chronic atorvas- tatin on eadioproteetion of ischemie posteonditioning in isolated rat hearts[J]. Cardiovasc Ther,2012:1755.
  • 4Bell RM, Yellon DM. Atorvastatin,administered at the onset of reperfusion,and independent of lipid lowering,protects the my- oeardium by up-regulating a pro-survival pathway[J]. J Am Coil Cardiol. 2003.41 ( 3 ) : 508-515.
  • 5Lee SH,Wolf PL,Escudero R,et al.Early expression of angiogen- esis factor inacute myocardial ischemia and infarction[J].N Engl J Med,2000,342 (9) : 626-633.
  • 6Martin C,Yu AY,Jiang BH,et al.Cardiac hypertrophy in chroni- cally anemic fetal shee:Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor l[J]. Am J Obstet Gy- necol, 1998,178 (3) :527-534.
  • 7Nishimoto-Hazuku A.Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-lalpha up- regulation in endothelial cells[J]. J Cardiovasc Pharmacol, 2008, 51 (3) :267-273.
  • 8Noireand J,Andriantsitohaina R. Recent insights in the paracrine modulation of cardiomyocyte contractility by cardiac endothelial cells[J]. Biomed Res Int, 2014, 2014: 923805.
  • 9Kubin T, Ando H,Scholz D, et al. Microvascular endothelial cells Imodel cultured adult cardiomyocytes and increase their survival [J]. Am J Physiol, 1999, 276: H2179-2187.
  • 10Lemmens K, Segers VF, Demolder M, et al. Role of neuregulin-l/ ErbB2 signaling in endothelium-cardiomyocyte cross-talk [ J ]. Biol Chem, 2006, 281: 19469-19477.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部